7.31 (3.54%) 1d
Seattle Genetics

They have antibody-based cancer treatments that he feels Gilead just overpaid for today in an acquisition. Merck announced it would take a $1 billion stake in SGEN. SGEN stock jumped from $150 Friday to $171 today. SGEN has stalled in recent months, but turns out this was undervalued.

Pharma & Healthcare
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Seattle Genetics(SGEN-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Seattle Genetics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Seattle Genetics(SGEN-Q) Frequently Asked Questions

What is Seattle Genetics stock symbol?

Seattle Genetics is a American stock, trading under the symbol SGEN-Q on the NASDAQ (SGEN). It is usually referred to as NASDAQ:SGEN or SGEN-Q

Is Seattle Genetics a buy or a sell?

In the last year, there was no coverage of Seattle Genetics published on Stockchase.

Is Seattle Genetics a good investment or a top pick?

Seattle Genetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Seattle Genetics.

Why is Seattle Genetics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Seattle Genetics worth watching?

0 stock analysts on Stockchase covered Seattle Genetics In the last year. It is a trending stock that is worth watching.

What is Seattle Genetics stock price?

On 2023-09-22, Seattle Genetics (SGEN-Q) stock closed at a price of $213.7.